These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10707824)

  • 1. Functional alterations of cardiac (Na,K)-ATPase in L-NAME induced hypertension.
    Vrbjar N; Bernátová I; Pechánová O
    Gen Physiol Biophys; 1999 Dec; 18 Suppl 1():10-2. PubMed ID: 10707824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of maturation on renal Na+/K+-atpase and its susceptibility to nitric oxide-deficient hypertension in rats.
    Javorková V; Vlkovicova J; Kunes J; Pechanova O; Zicha J; Vrbjar N
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):617-23. PubMed ID: 17581218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual effect of polyphenolic compounds on cardiac Na+/K+-ATPase during development and persistence of hypertension in rats.
    Vlkovicová J; Javorková V; Mézesová L; Pechánová O; Andriantsitohaina R; Vrbjar N
    Can J Physiol Pharmacol; 2009 Dec; 87(12):1046-54. PubMed ID: 20029541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of sodium and ATP affinities of the cardiac (Na,K)-ATPase during and after nitric oxide deficient hypertension.
    Vrbjar N; Bernátová I; Pechánová O
    Mol Cell Biochem; 1999 Dec; 202(1-2):141-7. PubMed ID: 10706004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium and ATP affinities of the cardiac Na(+),K(+)-ATPase in spontaneously hypertensive rats.
    Vrbjar N; Wachalová K; Sipola M; Vapaatalo H
    Gen Physiol Biophys; 2002 Sep; 21(3):303-13. PubMed ID: 12537353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender difference in functional properties of Na,K-ATPase in the heart of spontaneously hypertensive rats.
    Vlkovicová J; Javorková V; Pechánová O; Vrbjar N
    Life Sci; 2005 Jan; 76(9):971-82. PubMed ID: 15607327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes of sodium and ATP affinities of the renal Na,K-ATPase during and after nitric oxide-deficient hypertension.
    Vrbjar N; Javorková V; Pechánová O
    Physiol Res; 2002; 51(5):475-81. PubMed ID: 12470200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac membrane proteins and phospholipids in L-NAME induced hypertension.
    Ziaciková J; Pechánová O; Bernátová I; Vrbjar N
    Gen Physiol Biophys; 1999 Dec; 18 Suppl 1():13-5. PubMed ID: 10707825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term NO synthase inhibition and the Na+-binding properties of cardiac Na,K-ATPase.
    Vrbjar N; Strnisková M; Pechánová O; Gerová M
    Physiol Res; 2000; 49(1):65-70. PubMed ID: 10805406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the pyridoindole antioxidant stobadine on the cardiac Na(+),K(+)-ATPase in rats with streptozotocin-induced diabetes.
    Vlkovicová J; Javorková V; Stefek M; Kysel'ová Z; Gajdosíková A; Vrbjar N
    Gen Physiol Biophys; 2006 Jun; 25(2):111-24. PubMed ID: 16917126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbachol and nitric oxide inhibition of Na,K-ATPase activity in bovine ciliary processes.
    Ellis DZ; Nathanson JA; Rabe J; Sweadner KJ
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2625-31. PubMed ID: 11581209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term NO synthase inhibition and the ATP affinity of cardiac Na,K-ATPase.
    Vrbjar N; Strnisková M; Pechánová O; Gerová M
    Physiol Res; 2002; 51(6):565-9. PubMed ID: 12511179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic morphological alterations, glycogen content and cytochrome P450 activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME).
    Tarsitano CA; Paffaro VA; Pauli JR; da Silva GH; Saad MJ; Salgado I; da Cruz-Höfling MA; Hyslop S
    Cell Tissue Res; 2007 Jul; 329(1):45-58. PubMed ID: 17436021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory role of nitric oxide on the cardiac Na, K-ATPase in hypertension.
    Vlkovičová J; Javorková V; Mézešová L; Pecháňová O; Vrbjar N
    Physiol Res; 2008; 57 Suppl 2():S15-S22. PubMed ID: 18373397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antioxidant enzymes and effects of tempol on the development of hypertension induced by nitric oxide inhibition.
    Sainz J; Wangensteen R; Rodríguez Gómez I; Moreno JM; Chamorro V; Osuna A; Bueno P; Vargas F
    Am J Hypertens; 2005 Jun; 18(6):871-7. PubMed ID: 15925750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of bulbus Fritillaria water extract on blood pressure and renal functions in the L-NAME-induced hypertensive rats.
    Kang DG; Sohn EJ; Lee YM; Lee AS; Han JH; Kim TY; Lee HS
    J Ethnopharmacol; 2004 Mar; 91(1):51-6. PubMed ID: 15036467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EFFECTS OF NITRIC OXIDE SYNTHESIS INHIBITION ON THE Na,K-ATPase ACTIVITY IN THE KIDNEY.
    Kang DG; Kim JW; Lee J
    Pharmacol Res; 2000 Jan; 41(1):121-125. PubMed ID: 10712837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression of L-NAME-induced hypertension: the role of nitric oxide and endothelium-derived constricting factor.
    Paulis L; Zicha J; Kunes J; Hojna S; Behuliak M; Celec P; Kojsova S; Pechanova O; Simko F
    Hypertens Res; 2008 Apr; 31(4):793-803. PubMed ID: 18633192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic N-acetylcysteine administration prevents development of hypertension in N(omega)-nitro-L-arginine methyl ester-treated rats: the role of reactive oxygen species.
    Rauchová H; Pechánová O; Kunes J; Vokurková M; Dobesová Z; Zicha J
    Hypertens Res; 2005 May; 28(5):475-82. PubMed ID: 16156512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nitric oxide synthesis inhibition on the Na,K-ATPase activity in the kidney.
    Kang DG; Kim JW; Lee J
    Pharmacol Res; 2000 Jan; 41(1):123-7. PubMed ID: 10600280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.